Alector, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-06-30 EDT			5-day change	1st Jan Change
2.010 ^USD	-3.37%		+9.84%	+28.85%

05-07	Alector, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-05	Alector, Inc. - Special Call

Published on 09/22/2025 at 02:50 pm EDT - Modified on 09/22/2025 at 09:05 pm EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning, ladies and gentlemen, and welcome to Alector's conference call and webcast highlighting its progranulin franchise and Alector Brain

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

05-07	Alector, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-05	Alector, Inc. - Special Call
04-29	Alector to discontinue phase 2 trial of nivisnebart	RE
04-29	Alector Inc Discontinues Phase 2 Progress-Ad Trial of Nivisnebart and Provides Pipeline Update	CI
04-15	Alector Shares Rise After Cantor Fitzgerald Upgrade	MT
04-15	Cantor Fitzgerald Upgrades Alector to Overweight From Neutral	MT
03-12	Alector Files $400 Million Mixed Shelf	MT
03-10	Alector Shares Rise After BTIG Upgrade	MT
03-10	BTIG Upgrades Alector to Buy From Neutral, Price Target is $6	MT
03-06	Alector, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 03:10 PM
02-25	Alector, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-18	Alector, Inc.(NasdaqGS:ALEC) dropped from NASDAQ Biotechnology Index	CI
12-12	Alector Names Neil Berkley as CFO	MT
12-12	Alector, Inc. Appoints Neil Berkley as Chief Financial Officer, Effective December 10, 2025	CI
12-08	Alector, Inc. Presents at BofA Securities CNS Therapeutics Virtual Conference 2025, Dec-08-2025 02:25 PM